BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9021961)

  • 21. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E; Zuckerman T; Douer D; Qian D; Levine AM
    Cancer; 1998 Sep; 83(6):1224-30. PubMed ID: 9740089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes.
    Toyoda H; Fukuda Y; Nakano I; Katano Y; Takayama T; Kumada T; Nakano S; Takamatsu J; Saito H; Hayakawa T
    J Med Virol; 1998 Feb; 54(2):80-5. PubMed ID: 9496363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease.
    Sherman KE; Rouster SD; Mendenhall C; Thee D
    Hepatology; 1999 Jul; 30(1):265-70. PubMed ID: 10385665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K; Ito H; Watanabe K; Yano M; Ishigami M; Mizutani T; Sasaki Y; Goto H
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretransplantation hepatitis C virus quasispecies may be predictive of outcome after liver transplantation.
    Pelletier SJ; Raymond DP; Crabtree TD; Iezzoni JC; Sawyer RG; Hahn YS; Pruett TL
    Hepatology; 2000 Aug; 32(2):375-81. PubMed ID: 10915745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early evolution of hepatitis C virus (HCV) quasispecies after liver transplant for HCV-related disease.
    Schvoerer E; Soulier E; Royer C; Renaudin AC; Thumann C; Fafi-Kremer S; Brignon N; Doridot S; Meyer N; Pinson P; Ellero B; Woehl-Jaegle ML; Meyer C; Wolf P; Zachary P; Baumert T; Stoll-Keller F
    J Infect Dis; 2007 Aug; 196(4):528-36. PubMed ID: 17624837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.
    Lee JH; Teuber G; von Wagner M; Roth WK; Zeuzem S
    J Med Virol; 2000 Mar; 60(3):264-8. PubMed ID: 10630957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution of hepatitis C virus quasispecies in children with chronic hepatitis C.
    Gerotto M; Resti M; Dal Pero F; Migliorato I; Alberti A; Bortolotti F
    Infection; 2006 Apr; 34(2):62-5. PubMed ID: 16703294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability.
    Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype.
    Mihm S; Fayyazi A; Hartmann H; Ramadori G
    Hepatology; 1997 Mar; 25(3):735-9. PubMed ID: 9049227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation.
    Arenas JI; Gallegos-Orozco JF; Laskus T; Wilkinson J; Khatib A; Fasola C; Adair D; Radkowski M; Kibler KV; Nowicki M; Douglas D; Williams J; Netto G; Mulligan D; Klintmalm G; Rakela J; Vargas HE
    J Infect Dis; 2004 Jun; 189(11):2037-46. PubMed ID: 15143471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic variation characteristics of the envelope region of hepatitis C virus in the patients with chronic hepatitis].
    Chen S; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):219-22. PubMed ID: 12665923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus genetic variability in 52 human immunodeficiency virus-coinfected patients.
    Neau D; Jouvencel AC; Legrand E; Trimoulet P; Galperine T; Chitty I; Ventura M; Le Bail B; Morlat P; Lacut JY; Ragnaud JM; Dupon M; Fleury H; Lafon ME
    J Med Virol; 2003 Sep; 71(1):41-8. PubMed ID: 12858407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
    Brunetto MR; Suzuki T; Aizaky H; Flichman D; Colombatto P; Abate ML; Oliveri F; Matsuura Y; Bonino F; Miyamura T
    Ital J Gastroenterol; 1996 Dec; 28(9):499-504. PubMed ID: 9131394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relative stasis of hepatitis C virus quasispecies in natural duration].
    Wang QX; Wei L; Gao Y; Chen ZJ; Sun DG; Jiang D; Xu XY; Chen HS; Wang Y
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):841-3. PubMed ID: 12895335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational use of polymerase chain reaction--based detection of viral genomes in patients with serologic markers of hepatitis B or C virus infection.
    Pfeffel F; Oesterreicher C; Penner E; Ferenci P; Sillaber C; Fiedler R; Müller C
    Wien Klin Wochenschr; 1997 Jan; 109(1):20-4. PubMed ID: 9037744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
    Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
    J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.